FDA rejects ecstasy drug to treat PTDSD

Aug. 10 (UPI) — The U.S. Food and Drug Administration is not approving an application from Lykos Therapeutics for its use of MDMA, an ecstasy drug, to treat post-traumatic stress … Click to Continue »

View original article
Contributor: